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Abstract
Chronic thromboembolic disease (CTED) is suboptimally defined by a mean
pulmonary artery pressure (mPAP) <25 mmHg at rest in patients that remain
symptomatic from chronic pulmonary artery thrombi. To improve identifica-
tion of right ventricular (RV) pathology in patients with thromboembolic
obstruction, we hypothesized that the RV ventriculo-arterial (Ees/Ea) coupling
ratio at maximal stroke work (Ees/Eamax sw) derived from an animal model of
pulmonary obstruction may be used to identify occult RV dysfunction (low
Ees/Ea) or residual RV energetic reserve (high Ees/Ea). Eighteen open chested
pigs had conductance catheter RV pressure-volume (PV)-loops recorded dur-
ing PA snare to determine Ees/Eamax sw. This was then applied to 10 patients
with chronic thromboembolic pulmonary hypertension (CTEPH) and ten
patients with CTED, also assessed by RV conductance catheter and cardiopul-
monary exercise testing. All patients were then restratified by Ees/Ea. The ani-
mal model determined an Ees/Eamax sw = 0.68  0.23 threshold, either side of
which cardiac output and RV stroke work fell. Two patients with CTED were
identified with an Ees/Ea well below 0.68 suggesting occult RV dysfunction
whilst three patients with CTEPH demonstrated Ees/Ea ≥ 0.68 suggesting
residual RV energetic reserve. Ees/Ea > 0.68 and Ees/Ea < 0.68 subgroups
demonstrated constant RV stroke work but lower stroke volume (87.7  22.1
vs. 60.1  16.3 mL respectively, P = 0.006) and higher end-systolic pressure
(36.7  11.6 vs. 68.1  16.7 mmHg respectively, P < 0.001). Lower Ees/Ea in
CTED also correlated with reduced exercise ventilatory efficiency. Low Ees/Ea
aligns with features of RV maladaptation in CTED both at rest and on exer-
cise. Characterization of Ees/Ea in CTED may allow for better identification
of occult RV dysfunction.
Introduction
Chronic thromboembolic pulmonary hypertension
(CTEPH) occurs when organized thrombi obstruct the
pulmonary arteries (PA) increasing pulmonary vascular
resistance (PVR) and in turn elevating the mean PA pres-
sure (mPAP) (Simonneau et al. 2013). There is a subgroup
of patients who present with chronic thromboembolic dis-
ease (CTED), who have mPAP < 25 mmHg at rest, but
who are nevertheless symptomatic and possibly deserving
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of treatment. Right Ventricular (RV) dysfunction in these
patients may limit pulmonary pressure generation both at
rest and on exercise resulting in underestimation of disease
severity. Invasive hemodynamic assessment by right heart
catheterization is the gold standard diagnostic test and
these data are the primary determinant of prognosis
(Champion et al. 2009). However, it is pressure focused
and patients with CTED and occult RV dysfunction that is
contributory to their symptoms can be overlooked (Caste-
lain et al. 2001; Gan et al. 2007). The under-diagnosis of
RV dysfunction in CTED and the limited understanding of
its clinical course are significant unmet clinical needs. The
concept of ventriculo-arterial (Ees/Ea) coupling and RV
energetic reserve may offer novel insight in to the patho-
physiology of CTED and CTEPH and more accurately
define the disease state.
Pressure-volume (PV)-loop methodology allows for RV-
PA Ees/Ea coupling to be defined as the matching between
RV contractility (End-systolic elastance – Ees) and PA
afterload (Effective arterial elastance – Ea) (Kelly et al.
1992). There has been an emerging trend of clinical studies
performed using Ees/Ea coupling to detect changes in
patients with different PH etiologies and disease severity.
In patients with a clinical diagnosis of CTED/CTEPH
(McCabe et al. 2014), PH and associated systemic sclerosis
(Tedford et al. 2013), and those with PH and without
overt RV failure (Kuehne et al. 2004), it was demonstrated
that Ees/Ea uncoupling was due to a disproportional
increase in Ea and the inability to augment contractility
(Ees). These observations suggest that in early stage PH,
decreased Ees/Ea coupling is mainly reflected in increased
afterload (Ea) and insufficient augmentation of RV con-
tractility. However, in late stage PH, the continued pro-
gression of the disease state leads to the clinical
development of RV failure and further impairs Ees/Ea cou-
pling due to decreased contractility (Ees) (Kuehne et al.
2004). While there is potential for Ees/Ea coupling to be
used as a marker of RV function and illustrate the transi-
tion from RV adaptation to RV maladaptation, it still
remains unclear at what specific coupling ratio the RV
becomes uncoupled to the PA. Previous animal model data
suggests maximal stroke work (SW) was achieved at an
Ees/Eamax sw = 0.6 mmHg/mL, and RV dysfunction
ensued with any further increase in afterload. However,
this study determined Ees from a PA occlusion that is now
known to overestimate true Ees, and Ea was determined
from mean RV pressures rather than the end-systolic pres-
sure (ESP).
In health, the RV-PA is coupled to maintain optimal
cardiac output but it is possible to determine the maximal
SW in response to an acute artificial increase in afterload.
The Ees/Ea coupling ratio at which this point is reached is
termed Ees/Eamax sw. Above this threshold there is RV
energetic reserve, however, if this threshold is not main-
tained there is no energetic reserve and RV dysfunction
will ensue (Burkhoff and Sagawa 1986). We hypothesized
that Ees/Eamax sw defined in an animal model may be
applied clinically to detect occult RV dysfunction in
patients with CTED and potentially identify those patients
with CTEPH who retain RV energetic reserve. To corrobo-
rate the presence or absence of RV energetic reserve, con-
temporaneous cardiopulmonary exercise test data, where
available, was also analyzed in patients.
Methods
Animal model
Eighteen open-chested large white swine with a median
weight of 77 kg (range 67–92 kg) were studied.
Anesthetic protocol and lines
Swine were fasted for 12 h leading up to the procedure.
Water was allowed until one hour before premedication.
Premedication was undertaken with intramuscular injec-
tion of midazolam (0.5 mg/kg), ketamine (15 mg/kg) and
atropine (0.02 mg/kg). Induction of anesthesia was per-
formed using intravenous (IV) injection of fentanyl
(5.0 mcg/kg) over 5 min and propofol (2.0–4.0 mg/kg)
administered to effect. Oral endotracheal intubation was
established for institution of mechanical ventilation with
a respiratory rate of 12–15 breaths per min and tidal vol-
ume 10 ml/kg. The ventilator was set with volume control
with peak pressure <12 cmH2O and positive end-expira-
tory pressure of 5 cmH2O. Paralysis was induced with an
IV injection of pancuronium (0.15 mg/kg). Anaesthesia
was maintained using a constant infusion of fentanyl
(0.2 mcg/kg/min) and propofol (0.2 mg/kg/min). Arterial
and venous cannulas were located for measurement of
arterial blood pressure and central venous pressure,
respectively, using multi-parameter anesthesia monitor.
Prior to placing the conductance catheter into the RV
an IV injection of lidocaine (100 mg, total dose) was
administered.
Catheterization
Routine Swan-Gantz catheterization was performed via a
7-F sheath placed in the right jugular vein. Room temper-
ature saline injected in triplicate was used to determine
cardiac output by the standard thermodilution technique
(COTD). A midline sternotomy was performed and the
pericardium was removed. A 7-F, 8 electrode conductance
catheter (Millar Instruments, Houston, TX) was inserted
through a puncher in the RV apex and placed along the
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long axis of the ventricle (Fig. 1). PV-loop morphology
was used to confirm the correct placement of the catheter
within the RV.
Clinical study
Ten patients with a clinical diagnosis of CTEPH and 10
patients with a clinical diagnosis of CTED were invited to
participate. Exclusion criteria were a myocardial infarc-
tion in the preceding 12 weeks, previous permanent pace-
maker implant or atrial fibrillation.
Catheterization
Routine Swan-Ganz catheterization was performed via a
7-F sheath placed in the right femoral or jugular vein
using lidocaine local anesthetic. The catheter was
advanced and positioned in the right atrium (right atrial
pressures were measured), the RV and finally the PA (PA
pressures were measured). Cardiac output was determined
by thermodilution (COTD) in triplicate using 10 mL cool
saline injection. A 7-F, eight electrode conductance cathe-
ter was then inserted through the venous sheath,
Figure 1. (A) Animal model porcine heart instrumented with conductance catheter; (B) with PA snare partially occluded to increase RV
afterload; (C) RV PV-loops recorded during the PA snare. PV-loops are highlighted at baseline (blue), maximal efficiency (green) and maximal
SW (Red). (D) SW-Ea RV PV-loop relationship during the PA snare, (green) RV energetic reserve, (red) RV failure. (E) RV PV-loops recorded
during an IVC occlusion. PV-loops are highlighted at baseline (blue). SW is highlighted as the area contained within the baseline RV PV-loop. PE
is the area within the Ees and EDPVR pressure volume relationships. (F) Fluoroscopic image of conductance catheter located in the RV during
the clinical study; (G) Typical RV PV-loop morphology recorded for patients with CTED (blue) or CTEPH (red).
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advanced across the tricuspid valve and placed along the
long axis of the ventricle in to the RV apex under fluoro-
scopic guidance (Fig. 1).
Cardiopulmonary exercise testing
Where able, patients underwent symptom-limited incre-
mental cardiopulmonary exercise testing contemporane-
ous to right heart and conductance catheterization
procedures (within 1 week). Exercise testing was under-
taken according to ATS protocols aiming for an optimal
exercise test duration of 8–12 min.
Conductance calibration
A 20-kHz 30 lA current was applied to the outer most
electrodes to generate an intra-cavity electric field. The time
varying conductance, G(t), was calculated by measuring the
sum of the conductance between the five remaining sensing
electrode pairs. The conductance catheter was calibrated
for parallel conductance G(p) using the hypertonic saline
technique first described in the LV by Baan et al. (1984)
and has subsequently been used for the RV (McKay et al.
1984; McCabe et al. 2014). The time varying volume, V(t),
was calculated as follows: V(t) = 1/a 9 L2/rx[G(t) - G
(p)]; a the ratio of the conductance-derived volume to the
true volume calculated by COTD), L is the inter-electrode
distance, r is the blood conductivity (the reciprocal of the
specific resistivity of the blood measured directly with the
Millar cuvette) and G(p) is the parallel conductance (con-
ductance of fluids and tissues surrounding the RV).
Pressure volume loop data acquisition
Animal model
The conductance technique was used to measure the PV-
loop relationship during ventilation suspension to provide
a beat-to-beat assessment of RV function at steady state
for at least 5-cardiac cycles (Fig. 1). Two families of PV-
loops were recorded during ventilation suspension. A
snare was looped around the inferior vena cava (IVC)
and partially occluded to record a family of PV-loops
during a preload reduction. A separate snare was looped
around the PA and partially occluded over a 10–15 sec
period so that multiple data points could be recorded to
determine how RV hemodynamic parameters varied with
acute changes in PA afterload (Fig. 1).
Clinical study
The conductance technique was used to measure the PV-
loop relationship during ventilation breath hold at end-
expiration to provide a beat-to-beat assessment of RV
function at steady state for at least 5-cardiac cycles
(Fig. 1). It was not feasible to perform an IVC occlusion
in the clinical study.
Off-line RV hemodynamic measurements
The conductance catheter data was analyzed offline using
LabChart software (LabChart 7.0, ADInstruments, NSW,
Australia). Five steady-state PV-loops were recorded to
generate load-dependent parameters of systolic and dias-
tolic function. The systolic parameters of ventricular func-
tion were stroke work (SW), cardiac output (CO), stroke
volume (SV), ejection fraction (EF), end-systolic pressure
(ESP) and the maximum rate of isovolumic contraction
(dP/dtmax). The diastolic parameters of ventricular func-
tion were end-diastolic pressure (EDP), the maximum
rate of isovolumic relaxation (dP/dtmin), the effective arte-
rial elastance (Ea) (Kelly et al. 1992) and the time con-
stant of diastolic relaxation (Tau) (Weiss et al. 1976; Raff
and Glantz 1981; Matsubara et al. 1995). Ea is defined as
the ratio of end-systolic pressure (ESP) to stroke volume
(SV) and characterizes PA afterload from a combination
of PVR, pulmonary artery compliance and inductance
(Sunagawa et al. 1983, 1985; Morimont et al. 2008), to
provide a considerably better estimate of system beha-
viour than PVR alone (Greyson 2010). Tau represents the
exponential decay of the RV pressure during isovolumic
relaxation. Although Tau is considered load-dependent, it
is predominantly affected by heart rate, with an increased
heart rate reducing the time for diastolic filling. At a
steady heart rate it can be considered load-independent.
Animal model
A family of PV-loops recorded during an IVC snare were
used to determine the Ees. Ees is the gradient of the slope
of the end systolic pressure volume relationship (ESPVR)
and is a load-independent parameter of systolic contrac-
tility. Ees can be used with Ea to determine the ventricu-
loarterial-coupling ratio (Ees/Ea). A family of PV-loops
was recorded during a PA snare to determine how systolic
and diastolic parameters of RV function (as described
above) vary in response to increasing afterload (Ea) and
ventriculoarterial-coupling (Ees/Ea).
PV-loop morphology was used to determine maximal
RV efficiency from the SW/pressure volume area (PVA)
relationship. Ventricular efficiency is defined as the ratio
between SW and oxygen consumption (Burkhoff and
Sagawa 1986). PVA is a linear surrogate of myocardial
oxygen consumption (Suga et al. 1980, 1983, 1984). PVA
is the total mechanical work performed by the ventricle,
calculated from the sum of the external stroke work
2017 | Vol. 5 | Iss. 7 | e13227
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(SW – determined from the area contained within the
PV-loop) that propels the blood from the ventricle and
mechanical potential energy (PE – the area bound by the
ESPVR and EDPVR) stored in the ventricle at the end of
each contraction (Fig. 1) (Suga 1979).
Clinical study
Single beat estimation of Ees was performed using a Mat-
lab (MathWorks, MA) sinusoidal curve-fitting algorithm
to estimate the theoretical maximal isovolumic pressure
(Pmax) from a nonlinear extrapolation of the dP/dtmax
and dP/dtmin points on the RV pressure waveform (Brim-
ioulle et al. 2003). Ees was then calculated as the slope of
the Pmax-ESP divided by the SV (Brimioulle et al. 2003).
Statistical analysis
Data are expressed as mean  standard deviation and
P-values were calculated using a two-tailed unpaired stu-
dent t test for pairwise comparisons, and a Kruskal–Wallis
one-way ANOVA on Ranks followed by Tukey’s test for
multiple comparisons, unless otherwise stated. Categorical
data are expressed as number (percentage) and compared
with the Fisher Exact test. Linear regression analysis was used
to determine Ees. A P < 0.05 was considered statistically sig-
nificant. Analysis was performed using SigmaPlot 12.5 (Sys-
tat Software Inc, San Jose CA) statistical analysis package.
The primary outcome measure was Tau. The number of
subjects required was informed from previous work (Read
et al. 2011). To detect a change in Tau of 10  8 msec
between groups, we estimated 11 patients would be required
(a = 0.05, b = 0.2). We decided to recruit 20 to account for
possibly incomplete or poor quality datasets.
Ethics
Animal model
The animal study was approved by the Home Office
(Project Licence 70/7967). All animals received humane
care and the animal study adhered to the Code of practice
for the housing and care of animals bred, supplied, or
used for scientific purposes (Animals (Scientific) Proce-
dures Act, 1986, published 2014). The animal study was
performed to conform to the guidelines from Directive
2010/63/EU of the European Parliament on the protection
of animals used for scientific purposes.
Clinical study
The clinical study was approved by the local research
ethics committee (REC number 12/EE/0085), and
complied with the guidelines set out in the Declaration of
Helsinki. All participants gave written informed consent.
Results
Animal model
Baseline hemodynamic data are shown in Table 1. The
porcine model had similar hemodynamic data and weight
to humans. At baseline, none of the pigs had pulmonary
hypertension or evidence of RV dysfunction. Conductance
catheter data at baseline and then during the PA snare
are described in Table 2 and Fig. 2. This shows the RV
was modestly uncoupled at baseline (0.94  0.18) and
maximal efficiency occurred at a higher Ees/Ea than max-
imal SW: Ees/Ea 0.84  0.23 versus 0.68  0.23, respec-
tively. In terms of RV afterload, maximal efficiency was
achieved at a lower Ea than maximal SW: Ea (mmHg/
mL) 0.39  0.05 versus 0.50  0.14, respectively (Fig. 3).
While HR (P = 0.829) and Tau (P = 0.930) remained
constant there was a significant increase in dP/dtmin
(P < 0.001), explained by the load-dependency of
dP/dtmin and the significant rise in ESP (P < 0.001)
whilst EDP remained constant (P = 0.626). Below the
Ees/Eamax sw coupling ratio threshold of 0.68, RV SW,
efficiency, and CO declined.
Clinical study
Demographic human data from 10 patients with CTEPH
and 10 patients with CTED are shown in Table 3. We
confirmed that the mPAP (P < 0.001) and PVR
(P < 0.001) were normal in the CTED group and elevated
in the CTEPH group. Ea (P = 0.005) was elevated in the
CTEPH group. While HR (P = 0.560) and Tau
(P = 0.954) remained constant, there was a significant
increase in dP/dtmax (P = 0.016) and dP/dtmin
(P < 0.001) in those with CTEPH. This is explained by
the load-dependency of these measurements and the sig-
nificant rise in ESP (P < 0.001) in those with CTEPH
whilst EDP (P = 0.162) remained constant.
After reclassifying patients according to the Ees/Eamax
sw threshold established in the animal model (Table 4),
we demonstrated that mPAP (P = 0.006) and PVR
(P = 0.003) were normal in the Ees/Ea ≥ 0.68 group and
elevated in the Ees/Ea < 0.68 group. There was a signifi-
cant increase in HR (P = 0.04) in the Ees/Ea < 0.68
group. While Tau (P = 0.418) remained constant, there
was a significant increase in dP/dtmin (P = 0.003), again
explained by the load-dependency of this measurement
and the significant rise in ESP (P < 0.001) whilst EDP
(P = 0.103) remained constant. Although SW (P = 0.853)
remained constant between the Ees/Ea subgroups, there
ª 2017 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
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was a significant reduction in CO (P = 0.024), SV
(P = 0.006), ESV (P = 0.034) and EDV (P = 0.007) in
the Ees/Ea < 0.68 group. The differences in heart rate and
volumetric indices were not identified when patients were
stratified by pressure.
Two patients with CTED were identified with an
Ees/Ea < 0.68 indicating occult RV pathology (Fig. 4)
and three CTEPH patients still had residual RV ener-
getic reserve (Ees/Ea ≥ 0.68). This equated to a reclassi-
fication of 25% of the entire cohort. The Ees/Ea
coupling ratio for these three misclassified CTED
patients was 0.35 and 0.45, even though they presented
with normal mPAP (15 and 19 mmHg) and PVR (157
and 230 dyne/sec/cm5).
Cardiopulmonary exercise test data for patients with
CTED and CTEPH are displayed in Table S1 showing
exercise capacity assessed by VO2 (%) was marginally
higher in patients with CTED. Ees/Ea related to both VE/
VCO2 slope and peak end-tidal CO2 (Fig. 5) in patients
with CTED but showed no relationship to peak VO2
(r = 0.12, P > 0.05).
Discussion
This is the first study to use the conductance technique
to first determine the interaction between the RV and PA
in a large animal model to define an Ees/Ea threshold for
maximal SW, and then applied it in a cohort of patients
with CTED or CTEPH to help re-characterize RV patho-
physiology. The interaction between the RV and the PA
determines the external work and metabolic efficiency of
the ventricle. Animal model data have shown that the
Ees/Eamax sw was 0.68  0.23, beyond which RV dysfunc-
tion ensued. Redefining patients with CTED and CTEPH
using this Ees/Ea threshold revealed three patients with
CTEPH who had an Ees/Ea ≥ 0.68, demonstrating RV
energetic reserve and two patients with CTED who had
Ees/Ea < 0.68. This suggests occult RV dysfunction that
was not apparent on resting right heart catheterization.
On exercise, CTED patients with lower Ees/Ea also devel-
oped greater exercise ventilatory inefficiency with an
Table 1. Animal model hemodynamic data.
Group (n = 18)
Data
Weight, kg 78.8  6.7
Height, cm 128.2  5.2
Heart rate, BPM 101.3  2.0
MAP, mmHg 78.5  12.6
MPAP, mmHg 20.3  3.4
SvO2, % 65.5  8.7
COTD, L/min 6.6  1.1
CITD, L/min/m
2 4.2  0.6
Values are mean  SD.
MAP, mean arterial pressure; MPAP, mean pulmonary arterial
pressure; SvO2, mixed venous oxygen saturation; CO, cardiac out-
put; CI, cardiac index; TD, thermodilution.
Table 2. Animal model RV hemodynamic data at baseline, maximal efficiency, maximal SW and during the maximal PA occlusion.
Baseline Maximal efficiency Maximal SW Maximal PA occlusion P-value
CO, L/min 6.6  0.9 6.7  0.9 6.4  1.1 4.2  1.2 <0.001
ESV, mL 66.1  18.8 65.9  18.9 70.0  18.9 96.7  21.3 <0.001
EDV, mL 107.7  18.5 105.6  18.5 106  19.4 120.5  22.3 0.103
SV, mL 65.2  8.9 66.1  8.9 63.1  9.8 40.7  11.6 <0.001
EF, % 64.0  6.6 65.5  9.0 61.3  8.8 35.4  9.9 <0.001
ESP, mmHg 22.0  3.7 25.7  4.3 30.6  6.9 43.9  7.0 <0.001
EDP, mmHg 5.2  3.0 5.8  3.2 5.7  3.0 6.6  3.2 0.626
HR, BPM 101.7  1.8 101.8  1.8 101.4  1.8 103.2  6.1 0.829
dp/dtmax, mmHg/sec 307  61 352  77 350  71 344  55 0.176
dp/dtmin, mmHg/sec 217  36 248  50 299  56 360  54 <0.001
Tau, msec 61.5  27.0 58.7  27.4 56.6  25.0 61.5  23.6 0.930
Ea, mmHg/mL 0.34  0.06 0.39  0.05 0.50  0.14 1.18  0.43 <0.001
SW, mmHg.mL 899  205 1138  263 1246  285 844  393 0.002
PVA, mmHg.mL 1616  709 1327  424 1614  483 2152  621 0.002
SW/PVA 0.63  0.22 0.90  0.21 0.80  0.20 0.42  0.23 <0.001
Ees/Ea 0.94  0.18 0.84  0.23 0.68  0.23 0.32  0.15 <0.001
Values are mean  SD.
CO, cardiac output; ESV, end-systolic volume; EDV, end-diastolic volume; SV, stroke volume; EF, ejection fraction; ESP, end-systolic pressure;
EDP, end-diastolic pressure; HR, heart rate; dP/dt max, maximum rate of isovolumic contraction; dP/dt min, maximum rate of isovolumic relax-
ation; Tau, time constant of diastolic relaxation; Ea, effective arterial elastance; SW, stroke work; PVA, pressure volume area; SW/PVA, RV effi-
ciency; Ees/Ea, ventriculoarterial coupling ratio.
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increased hyperventilatory response. This supports a pos-
sible link between resting RV dysfunction detected by
conductance catheterization and unfavorable RV adapta-
tion to exercise. These findings provide novel insight into
RV energetics observed in CTED and CTEPH, potentially
improving on the current disease definition in CTED and
identifying those with RV maladaptation.
Animal model
We establish that while maximal efficiency is important
from the perspective of understanding ideal energy trans-
fer conditions between RV work and oxygen consump-
tion, the threshold of maximal SW is the determinant
factor in RV failure. We have demonstrated acute RV
adaptation in response to acute changes in afterload.
There is an immediate response where the RV systolic
pressure rises to maintain ejection. Then, as the afterload
continues to increase, there are only relatively small
increases to EDP and EDV as the RV dilates and distends
to accommodate the increasing systolic pressure required
to attempt to facilitate ejection. As the systolic pressure
rises beyond the threshold point of maximal SW, ESV
increases and combined with the relatively small change
in EDV, this results in a reduction in SV. This reduction
in SV causes a decline in CO and SW, as the RV fails to
maintain sufficient output against the increasing loading
conditions. Therefore, in terms of efficiency and SW, as
the afterload increases from baseline, RV output is ade-
quately maintained through the arbitrary point of maxi-
mal efficiency until the loading conditions reach a
threshold point of maximal SW at an Ees/Ea = 0.68.
Beyond this threshold of maximal SW, SW and CO may
continue to offer sufficient output to meet demand at
rest. However, if the afterload loading conditions are
increased further (as is observed during modest exercise),
PA Occlusion time point
BL Max Eff Max SW Max Occ
SW
 (m
m
H
g.
m
L)
0
200
400
600
800
1000
1200
1400
1600
1800
2000
*
PA Occlusion time point
BL Max Eff Max SW Max Occ
Ef
fic
ie
nc
y 
(S
W
/P
VA
)
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
1.6
***
***
PA Occlusion time point
BL Max Eff Max SW Max Occ
C
O
 (m
L/
h)
0
1000
2000
3000
4000
5000
6000
7000
8000
9000
10000
***
PA Occlusion time point
BL Max Eff Max SW Max Occ
Ea
 (m
m
H
g/
m
L)
0.0
0.5
1.0
1.5
2.0
***
*
PA Occlusion time point
BL Max Eff Max SW Max Occ
ES
V 
(m
L)
0
20
40
60
80
100
120
140
160
180
***
PA Occlusion time point
BL Max Eff Max SW Max Occ
ES
P 
(m
m
H
g)
0
10
20
30
40
50
60
70
***
***
A
B
C
D
E
F
Figure 2. Animal model (n = 18) RV hemodynamic data for (A) SW; (B) CO; (C) ESV; (D) SW/PVA; (E) Ea; and (F) ESP at baseline (BL) and the
PA occlusion time point for maximal efficiency (Max Eff), maximal SW (Max SW) and maximal PA occlusion (Max Occ.). *P < 0.05; **P < 0.01;
***P < 0.001.
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there is insufficient RV energetic reserve and the RV will
fail to meet demand. Ees/Ea can be used as a surrogate
load-independent indicator for RV failure. Evaluating the
Ees/Ea at maximal SW could better determine disease
severity and guide management.
We have established a threshold for RV-PA ventricu-
loarterial uncoupling in an animal model, beyond which,
there is insufficient energetic reserve to maintain adequate
RV function. Theoretical models have predicted optimal
mechanical coupling corresponded to an Ees/Ea = 1
(Sunagawa et al. 1984); with current literature suggesting
in an healthy individual RV-PA ventriculoarterial cou-
pling is between 1 and 2 (Naeije and Manes 2014) and
that the values for the LV and RV are comparable. While
we demonstrate agreement with previous work at baseline
(Guihaire et al. 2013), with slight uncoupling between the
RV-PA at rest (Ees/Ea = 0.94  0.18), our work has
shown that maximal SW occurs at an Ees/
Ea = 0.68  0.23, and that uncoupling only occurred
beyond this threshold as there was insufficient RV ener-
getic reserve to maintain function as Ea increased further.
This finding is supported by previous work (Fourie et al.
1992) where authors suggested the RV uncoupled around
an Ees/Ea = 0.6 mmHg/mL. One explanation for this
apparent inefficient energy transfer between the RV and
PA could be the complex pulmonary vascular structure.
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Figure 3. Animal model relation between afterload quantified by Ea and (A) SW; (B) SW/PVA; and (C) CO. Animal model relation between the
ventriculo-arterial coupling ratio (Ees/Ea) and (D) SW; (E) SW/PVA; and (F) CO. Pooled data from 18 hearts are shown (n = 324). Mean
regression lines with 95% prediction intervals are displayed.
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Whereas, the LV is coupled with an elastic aorta and all
energy expended during the pulsatile contraction is con-
verted into flow energy due to the elastic recoil of the
aorta (Yaginuma et al. 1985; Sasayama and Asanoi 1991),
Table 3. Demographics, right heart catheterization and RV hemo-
dynamic data when classifying patients by mPAP at rest.
mPAP ≤ 25
(n = 10)
mPAP > 25
(n = 10) P-value
Demographics
Age, years 55  17 51  14 0.564
Male sex, N (%) 4 (40.0) 6 (60.0) 0.656
BMI, kg/m2 31.2  8.2 29.2  4.4 0.880
6MWD, m 369  79 377  134 0.902
WHO Class II/III, N (%) 10 (100.0) 10 (100.0) 1.000
Right heart catheter
mPAP, mmHg 18.8  5.5 39.7  7.1 <0.001
Systolic PAP, mmHg 30.7  9.6 66.8  16.4 <0.001
Diastolic PAP, mmHg 10.1  4.8 24.1  6.6 <0.001
mRAP, mmHg 5.8  4.2 8.0  3.5 0.109
PCWP, mmHg 8.3  4.3 10.8  4.9 0.244
RV EDP, mmHg 5.8  3.5 10.1  3.4 0.012
SvO2, % 74.1  4.2 71.5  6.3 0.305
CO, L/min 5.3  1.3 4.7  1.0 0.249
CI, L/min/m2 2.6  0.3 2.4  0.6 0.334
PVR, dyne/sec/cm5 163  57 573  220 <0.001
RV Hemodynamics
Heart Rate, BPM 68  10 71  13 0.560
SW, mmHg.mL 1402  500 2018  732 0.041
CO, L/min 5.3  1.4 4.9  1.0 0.436
ESP, mmHg 34.2  7.1 67.4  16.6 <0.001
EDP, mmHg 10.3  4.3 13.1  4.4 0.162
ESV, mL 111.0  44.4 85.2  26.2 0.241
EDV, mL 149.8  44.4 118.2  37.7 0.104
SV, mL 78.7  22.0 71.8  26.3 0.532
EF, % 51.6  8.3 55.5  9.9 0.354
dP/dtmax, mmHg/sec 351  76 502  181 0.016
dP/dtmin, mmHg/sec -326  92 -618  173 <0.001
Ea, mmHg/mL 0.47  0.18 1.10  0.52 0.005
Tau, msec 63.9  17.3 64.3  16.4 0.954
Ees/Ea 2.29  1.68 0.72  0.59 0.02
Values are mean  SD or n (%).
BMI, body mass index; 6MWD, 6 min walking distance; WHO
Class, world health organisation classification; mPAP, mean pul-
monary arterial pressure; mRAP, mean right atrial pressure; PCWP,
pulmonary capillary wedge pressure; RV EDP, right ventricular
end-diastolic pressure; SvO2, mixed venous oxygen saturations;
CO, cardiac output; CI, cardiac index; PVR, pulmonary vascular
resistance; SW, stroke work; ESP, end-systolic pressure; EDP, end-
diastolic pressure; ESV, end-systolic volume; EDV, end-diastolic vol-
ume; SV, stroke volume; EF, ejection fraction; dP/dtmax, maximum
rate of isovolumic contraction; dP/dtmin, maximum rate of isovolu-
mic relaxation; Ea, effective arterial Elastance; Tau, time constant
of diastolic relaxation; Ees/Ea, Single-beat ventriculo-arterial cou-
pling ratio.
Table 4. Demographics, right heart catheterization and RV hemo-
dynamic data when reclassifying patients with CTED or CTEPH by
Ees/Eamax sw determined from an animal model.
Ees/Ea ≥ 0.68
(n = 11)
Ees/Ea < 0.68
(n = 9) P-value
Demographics
CTED, N (%) 8 (72.7) 2 (27.3) 0.072
CTEPH, N (%) 3 (22.2) 7 (77.7) 0.073
Age, years 55  16 50  16 0.516
Male sex, N (%) 5 (45.4) 5 (55.6) 0.653
BMI, kg/m2 30.9  7.4 29.1  4.9 0.804
6MWD, m 380  81 364  137 0.747
WHO class (II/III) 11 (100.0) 9 (100.0) 1.000
Right heart catheter
mPAP, mmHg 22.8  8.0 37.1  12.5 0.006
Systolic PAP, mmHg 38.8  17.1 60.9  23.5 0.026
Diastolic PAP, mmHg 12.4  6.0 22.9  9.1 0.006
mRAP, mmHg 7.1  4.7 6.7  3.0 0.817
PCWP, mmHg 10.8  5.8 8.0  2.2 0.144
RV EDP, mmHg 7.6  4.5 8.3  3.5 0.709
SvO2, % 74.5  4.7 71.0  6.0 0.120
CO, L/min 5.3  1.3 4.6  1.0 0.217
CI, L/min/m2 2.7  0.3 2.3  0.5 0.082
PVR, dyne/sec/cm5 181  78 554  250 0.003
RV hemodynamics
Heart rate, BPM 65  11 75  10 0.04
SW, mmHg.mL 1683  663 1743  755 0.853
CO, L/min 5.6  1.2 4.4  0.8 0.024
ESP, mmHg 36.7  11.6 68.1  16.7 <0.001
EDP, mmHg 10.2  3.8 13.5  4.7 0.103
ESV, mL 114.0  36.3 78.6  31.4 0.034
EDV, mL 156.1  35.5 107.0  37.1 0.007
SV, mL 87.7  22.1 60.1  16.5 0.006
EF, % 53.3  9.8 54.0  8.8 0.875
dP/dtmax, mmHg/sec 385  114 475  190 0.173
dP/dtmin, mmHg/sec -358  136 -612  183 0.003
Ea, mmHg/mL 0.42  0.10 1.22  0.43 <0.001
Tau, msec 67.1  13.7 60.8  19.2 0.418
Ees/Ea 2.38  1.49 0.45  0.14 <0.001
Values are mean  SD or n (%).
CTED, chronic thromboembolic disease; CTEPH, chronic throm-
boembolic pulmonary hypertension; BMI, body mass index;
6MWD, 6 min walking distance; WHO Class, world health
organisation classification; mPAP, mean pulmonary arterial pres-
sure; mRAP, mean right atrial pressure; PCWP, pulmonary capil-
lary wedge pressure; RV EDP, right ventricular end-diastolic
pressure; SvO2, mixed venous oxygen saturations; CO, cardiac
output; CI, cardiac index; PVR, pulmonary vascular resistance;
SW, stroke work; ESP, end-systolic pressure; EDP, end-diastolic
pressure; ESV, end-systolic volume; EDV, end-diastolic volume;
SV, stroke volume; EF, ejection fraction; dP/dtmax, maximum rate
of isovolumic contraction; dP/dtmin, maximum rate of isovolumic
relaxation; Ea, effective arterial Elastance; Tau, time constant of
diastolic relaxation; Ees/Ea, single-beat ventriculo-arterial coupling
ratio.
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the pulmonary artery has relatively short elastic proximal
vessels which branch into the pulmonary trunk, so that
25–40% of the energy expended during the contraction of
the RV is not converted into flow energy due to the
restricted elastic recoil of the pulmonary vessels (Grignola
et al. 2007; Saouti et al. 2010). This would explain the
lower coupling ratio we observed.
Translation into the clinical cohort
CTED is poorly defined and as a result is difficult to
diagnose and treat. This study for the first time
evaluates not only Ees/Ea but also RV efficiency (SW/
PVA) in this condition. We used an animal model to
define the Ees/Ea coupling ratio at maximal SW and,
in one analysis, apply this threshold to re-evaluate
patients with CTED and CTEPH by assessing RV func-
tion. Previous studies have relied on single-beat estima-
tion methodologies to determine Ees from a real end-
systolic point on the baseline PV-loop and a second
theoretical point (Bellofiore and Chesler 2013). This
enables RV-PA ventriculoarterial-coupling ratio adapta-
tion in response to increased loading conditions in PH
to be observed. Our group has used this methodology
Figure 4. The individual data points for the patients with CTED (n = 10) or CTEPH (n = 10) overlaid on top of the mean regression lines
determined from the animal model for the relation between afterload quantified by Ea and (A) SW; (B) SW/PVA; and (C) CO. The individual
data points for the patients with CTED (n = 10) or CTEPH (n = 10) overlaid on top of the mean regression lines determined from the animal
model for the relation between ventriculo-arterial coupling ratio (Ees/Ea) and (D) SW; (E) SW/PVA; and (F) CO.
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to confirm that ventriculoarterial-coupling is maintained
in patients with CTED. Proportional increases in both
Ees and Ea occur in CTED, whereas in patients with
CTEPH, Ea increases disproportionately and the RV
becomes uncoupled from the PA (McCabe et al. 2014).
The inability to adapt and increase resting contractility
(Ees) in the presence of increased afterload also appears
to be a particular problem in patients with systemic
sclerosis and PH resulting in greater uncoupling in this
cohort as well (Tedford et al. 2013).
Applying an Ees/Ea coupling ratio threshold derived
from our animal model suggested that in the majority of
our CTED patients, the RV retained its energetic reserve
whereas in only two patients, resting RV function appears
to be compromised. Conversely whilst most patients with
CTEPH have significant RV dysfunction, a few retain a
RV energetic reserve. After reclassification, those patients
with Ees/Ea uncoupling suffer a reduced SV, and there-
fore, HR and ESP is significantly increased to maintain
adequate CO at rest. Reclassification was made in 25% of
our cohort which may be clinically important. In those
CTED patients that lack RV energetic reserve, endarterec-
tomy or pulmonary vasodilator therapy may be indicated.
An implication of reduced RV energetic reserve in
CTED may be an impaired RV exercise response, giving
rise to impaired exercise ventilation-perfusion matching.
This is supported by higher VE/VCO2 slope gradients in
patients with low Ees/Ea values. Higher end-tidal CO2
values at anaerobic threshold also suggest preserved car-
dio-ventilatory coupling with a lower hyperventilatory
response to exercise in patients with preserved Ees/Ea val-
ues. A recent study of 42 patients with CTED undergoing
pulmonary endarterectomy demonstrated an improve-
ment in 6-min walk distance of 49 m at 12 months post-
operatively (Taboada et al. 2014). This effect may have
been exaggerated with more accurate triaging by assessing
V-A coupling. This study alludes to dynamic interplay
between the constituents of pulmonary afterload and
exercise capacity in CTED as post-operative changes in
routine assessed pulmonary hemodynamics were relatively
small. Further work studying RV energetics and treatment
response is therefore justified in a larger population of
CTED patients.
Study limitations
Some limitations of our study must be recognized. The
porcine model of RV-PA ventriculoarterial interaction has
an open pericardium that reduces RV contractility and
partly explains why porcine PVR is higher than in
humans. However, this remains the best physiological
model of assessing the response of normal RV function to
changes in afterload, as LV-RV interdependence is
retained. Furthermore, fentanyl can adversely affect con-
tractility and we inserted the conductance catheter api-
cally in the animal model that may have further
diminished RV contractility. Nevertheless, it remains the
most commonly studied model (Kuehne et al. 2004; Grig-
nola et al. 2007; Read et al. 2011; Simonneau et al. 2013;
McCabe et al. 2014). The animal model assessed the effect
of acute afterload perturbation on RV function whereas
in the human model the RV is chronically loaded and the
influence of remodelling in the human model is a possi-
ble and important unaccounted confounder. We were not
able to insert an additional venous sheath for IVC balloon
occlusion in the clinical studies. Therefore, we used single
beat methodology to determine the Ees/Ea coupling ratio.
While this method has not been validated in the RV of
patients with PH, it remains commonly used by others
(Kuehne et al. 2004; Herberg et al. 2013; McCabe et al.
2014). This small pilot study will need to be repeated in a
larger clinical trial to fully determine the clinical implica-
tions of our findings and in particular to better under-
stand RV and gas exchange exercise characteristics in
CTED. We were unable to determine the prognostic sig-
nificance of using Ea as a marker of RV dysfunction in
this and other causes of PH and this remains the focus of
further research. Finally, patients did not have biventricu-
lar conductance measurements performed and we cannot
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Figure 5. The individual data points for the patients with CTED
(n = 8) for the relation between Ees/Ea and cardiopulmonary
exercise (A) VE/VCO2 and (B) peak end-tidal CO2. Linear regression
lines with 95% confidence intervals are displayed.
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comment on the effect of ventricular interdependence on
our findings. All the patients studied had confirmed nor-
mal LV function on echocardiography and normal capil-
lary wedge pressures at right heart catheterization. It is
unlikely that LV dysfunction unduly influenced the func-
tional changes observed in the RV.
Conclusions
The Ees/Ea coupling ratio at maximal SW determined
from an animal model defined an Ees/Ea threshold of 0.68,
beyond which RV dysfunction occurs. Using this threshold
we have detected occult RV pathology at rest in patients
with otherwise normal pulmonary hemodynamics, and
demonstrated RV energetic reserve in some cases of
CTEPH. Detailed Ees/Ea coupling data may improve the
diagnostic accuracy of patients with chronic pulmonary
thromboemboli and usefully influence their management.
Acknowledgments
We thank the staff in the cardiac catheter laboratory at
Papworth Hospital and the laboratory staff at the Royal
Veterinary College for their assistance throughout the
study.
Conflict of Interest
None. There are no relationships with industry.
References
Baan, J., E. T. van der Velde, H. G. de Bruin, G. J. Smeenk, J.
Koops, A. D. van Dijk, et al. 1984. Continuous
measurement of left ventricular volume in animals and
humans by conductance catheter. Circulation 70:812–823.
Bellofiore, A., and N. C. Chesler. 2013. Methods for measuring
right ventricular function and hemodynamic coupling with
the pulmonary vasculature. Ann. Biomed. Eng. 41:1384–
1398.
Brimioulle, S., P. Wauthy, P. Ewalenko, B. Rondelet, F.
Vermeulen, F. Kerbaul, et al. 2003. Single-beat estimation of
right ventricular end-systolic pressure-volume relationship.
Am. J. Physiol. Heart Circ. Physiol. 284:H1625–H1630.
Burkhoff, D., and K. Sagawa. 1986. Ventricular efficiency
predicted by an analytical model. Am. J. Physiol. 250:
R1021–R1027.
Castelain, V., P. Herve, Y. Lecarpentier, P. Duroux, G.
Simonneau, and D. Chemla. 2001. Pulmonary artery pulse
pressure and wave reflection in chronic pulmonary
thromboembolism and primary pulmonary hypertension. J.
Am. Coll. Cardiol. 37:1085–1092.
Champion, H. C., E. D. Michelakis, and P. M. Hassoun. 2009.
Comprehensive invasive and noninvasive approach to the
right ventricle-pulmonary circulation unit: state of the art
and clinical and research implications. Circulation 120:992–
1007.
Fourie, P. R., A. R. Coetzee, and C. T. Bolliger. 1992.
Pulmonary artery compliance: its role in right ventricular-
arterial coupling. Cardiovasc. Res. 26:839–844.
Gan, C. T., S. Holverda, J. T. Marcus, W. J. Paulus, K. M.
Marques, J. G. Bronzwaer, et al. 2007. Right ventricular
diastolic dysfunction and the acute effects of sildenafil in
pulmonary hypertension patients. Chest 132:11–17.
Greyson, C. R. 2010. The right ventricle and pulmonary
circulation: basic concepts. Rev. Esp. Cardiol. 63:81–95.
Grignola, J. C., F. Gines, D. Bia, and R. Armentano. 2007.
Improved right ventricular-vascular coupling during
active pulmonary hypertension. Int. J. Cardiol. 115:171–
182.
Guihaire, J., F. Haddad, D. Boulate, B. Decante, A. Y. Denault,
J. Wu, et al. 2013. Non-invasive indices of right ventricular
function are markers of ventricular-arterial coupling rather
than ventricular contractility: insights from a porcine model
of chronic pressure overload. Eur. Heart J. Cardiovasc.
Imaging 14:1140–1149.
Herberg, U., E. Gatzweiler, T. Breuer, and J. Breuer. 2013.
Ventricular pressure-volume loops obtained by 3D real-time
echocardiography and mini pressure wire-a feasibility study.
Clin. Res. Cardiol. 102:427–438.
Kelly, R. P., C. T. Ting, T. M. Yang, C. P. Liu, W. L.
Maughan, M. S. Chang, et al. 1992. Effective arterial
elastance as index of arterial vascular load in humans.
Circulation 86:513–521.
Kuehne, T., S. Yilmaz, C. Meinus, P. Moore, M. Saeed, O.
Weber, et al. 2004. Magnetic resonance imaging-guided
transcatheter implantation of a prosthetic valve in aortic
valve position: feasibility study in swine. J. Am. Coll.
Cardiol. 44:2247–2249.
Matsubara, H., M. Takaki, S. Yasuhara, J. Araki, and H. Suga.
1995. Logistic time constant of isovolumic relaxation
pressure-time curve in the canine left ventricle. Better
alternative to exponential time constant. Circulation
92:2318–2326.
McCabe, C., P. A. White, S. P. Hoole, R. G. Axell, A. N.
Priest, D. Gopalan, et al. 2014. Right ventricular dysfunction
in chronic thromboembolic obstruction of the pulmonary
artery: a pressure-volume study using the conductance
catheter. J. Appl. Physiology 116:355–363.
McKay, R. G., J. R. Spears, J. M. Aroesty, D. S. Baim, H. D.
Royal, G. V. Heller, et al. 1984. Instantaneous measurement
of left and right ventricular stroke volume and pressure-
volume relationships with an impedance catheter.
Circulation 69:703–710.
Morimont, P., B. Lambermont, A. Ghuysen, P. Gerard, P.
Kolh, P. Lancellotti, et al. 2008. Effective arterial elastance as
an index of pulmonary vascular load. Am. J. Physiol. Heart
Circ. Physiol. 294:H2736–H2742.
2017 | Vol. 5 | Iss. 7 | e13227
Page 12
ª 2017 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
The Physiological Society and the American Physiological Society.
Detecting RV Dysfunction in CTED R. G. Axell et al.
Naeije, R., and A. Manes. 2014. The right ventricle in
pulmonary arterial hypertension. Eur. Resp. Rev. 23:476–
487.
Raff, G. L., and S. A. Glantz. 1981. Volume loading slows left
ventricular isovolumic relaxation rate. Evidence of load-
dependent relaxation in the intact dog heart. Circ. Res.
48:813–824.
Read, P. A., S. P. Hoole, P. A. White, F. Z. Khan, M.
O’Sullivan, N. E. West, et al. 2011. A pilot study to assess
whether glucagon-like peptide-1 protects the heart from
ischemic dysfunction and attenuates stunning after coronary
balloon occlusion in humans. Circ. Cardiovasc. Interv.
4:266–272.
Saouti, N., N. Westerhof, F. Helderman, J. T. Marcus, A.
Boonstra, P. E. Postmus, et al. 2010. Right ventricular
oscillatory power is a constant fraction of total power
irrespective of pulmonary artery pressure. Am. J. Respir.
Crit. Care Med. 182:1315–1320.
Sasayama, S., and H. Asanoi. 1991. Coupling between the
heart and arterial system in heart failure. Am. J. Med.
90:14S–18S.
Simonneau, G., M. A. Gatzoulis, I. Adatia, D. Celermajer, C.
Denton, A. Ghofrani, et al. 2013. Updated clinical
classification of pulmonary hypertension. J. Am. Coll.
Cardiol. 62:D34–D41.
Suga, H. 1979. Total mechanical energy of a ventricle model
and cardiac oxygen consumption. Am. J. Physiol. 236:H498–
H505.
Suga, H., T. Hayashi, M. Shirahata, and I. Ninomiya. 1980.
Critical evaluation of left ventricular systolic pressure
volume areas as predictor of oxygen consumption rate. Jpn.
J. Physiol. 30:907–919.
Suga, H., R. Hisano, Y. Goto, O. Yamada, and Y. Igarashi.
1983. Effect of positive inotropic agents on the relation
between oxygen consumption and systolic pressure volume
area in canine left ventricle. Circ. Res. 53:306–318.
Suga, H., O. Yamada, Y. Goto, Y. Igarashi, and H. Ishiguri.
1984. Constant mechanical efficiency of contractile
machinery of canine left ventricle under different loading
and inotropic conditions. Jpn. J. Physiol. 34:679–698.
Sunagawa, K., W. L. Maughan, D. Burkhoff, and K. Sagawa.
1983. Left ventricular interaction with arterial load studied
in isolated canine ventricle. Am. J. Physiol. 245:H773–H780.
Sunagawa, K., K. Sagawa, and W. L. Maughan. 1984.
Ventricular interaction with the loading system. Ann.
Biomed. Eng. 12:163–189.
Sunagawa, K., W. L. Maughan, and K. Sagawa. 1985. Optimal
arterial resistance for the maximal stroke work studied in
isolated canine left ventricle. Circ. Res. 56:586–595.
Taboada, D., J. Pepke-Zaba, D. P. Jenkins, M. Berman, C. M.
Treacy, J. E. Cannon, et al. 2014. Outcome of pulmonary
endarterectomy in symptomatic chronic thromboembolic
disease. Eur. Respir. J. 44:1635–1645.
Tedford, R. J., J. O. Mudd, R. E. Girgis, S. C. Mathai, A. L.
Zaiman, T. Housten-Harris, et al. 2013. Right ventricular
dysfunction in systemic sclerosis-associated pulmonary
arterial hypertension. Circ. Heart Fail. 6:953–963.
Weiss, J. L., J. W. Frederiksen, and M. L. Weisfeldt. 1976.
Hemodynamic determinants of the time-course of fall in
canine left ventricular pressure. J. Clin. Invest. 58:751–760.
Yaginuma, T., T. Noda, M. Tsuchiya, K. Takazawa, H. Tanaka,
K. Kotoda, et al. 1985. Interaction of left ventricular
contraction and aortic input impedance in experimental and
clinical studies. Jpn. Circ. J. 49:206–214.
Supporting Information
Additional Supporting Information may be found in the
online version of this article:
Table S1. Cardiopulmonary exercise testing data when
classifying patients by mPAP at rest.
ª 2017 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
The Physiological Society and the American Physiological Society.
2017 | Vol. 5 | Iss. 7 | e13227
Page 13
R. G. Axell et al. Detecting RV Dysfunction in CTED
